ArticleTranslational lung cancer research2024

Health-related quality of life analysis from ENTER, a randomized, controlled phase III trial of whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases.

Fei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.